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Myosin-cross-reactive antigen (MCRA) protein
from Bifidobacterium breve is a FAD-dependent
fatty acid hydratase which has a function in
stress protection
Eva Rosberg-Cody1,2,4, Alena Liavonchanka3, Cornelia Göbel3, R Paul Ross1,4, Orla O’Sullivan4, Gerald F Fitzgerald1,2,
Ivo Feussner3, Catherine Stanton1,4*
Abstract
Background: The aim of this study was to determine the catalytic activity and physiological role of myosin-cross-
reactive antigen (MCRA) from Bifidobacterium breve NCIMB 702258. MCRA from B. breve NCIMB 702258 was cloned,
sequenced and expressed in heterologous hosts (Lactococcus and Corynebacterium) and the recombinant proteins
assessed for enzymatic activity against fatty acid substrates.
Results: MCRA catalysed the conversion of palmitoleic, oleic and linoleic acids to the corresponding 10-hydroxy
fatty acids, but shorter chain fatty acids were not used as substrates, while the presence of trans-double bonds and
double bonds beyond the position C12 abolished hydratase activity. The hydroxy fatty acids produced were not
metabolised further. We also found that heterologous Lactococcus and Corynebacterium expressing MCRA
accumulated increasing amounts of 10-HOA and 10-HOE in the culture medium. Furthermore, the heterologous
cultures exhibited less sensitivity to heat and solvent stresses compared to corresponding controls.
Conclusions: MCRA protein in B. breve can be classified as a FAD-containing double bond hydratase, within the
carbon-oxygen lyase family, which may be catalysing the first step in conjugated linoleic acid (CLA) production,
and this protein has an additional function in bacterial stress protection.
Background
The Streptococcal 67 kDa MCRA-like proteins represent
a family of proteins which are present in a wide range of
bacteria. It has been reported that some members of the
MCRA-like proteins have fatty acid hydratase activity
[1,2]. Recently, the MCRA protein from Streptococcus
pyogenes M49 was reported to be a FAD-containing
enzyme, which acts as hydratase on cis-9 (9Z) -
and trans-11 (11E)-double bonds of C-16, C-18 non-
esterified fatty acids producing 10-hydroxy and
10,13-dihydroxy fatty acids [1].
The expression of the mcra gene was found to be up-
regulated by the stress responsive alternative transcrip-
tion factor sB in Staphylococcus aureus [3]. It could be
speculated that in vivo conditions such as high tempera-
ture at the site of infection, leading to stress in S. aureus
may induce the stress responsive sB transcription factor
[3]. It is a general belief that the MCRA protein is
involved in virulence in Staphylococcus and Streptococ-
cus [4]. A 67 kDa streptococcal MCRA protein was up-
regulated in group A Streptococcus during experimental
mouse soft tissue infection [5] and in the asymptomatic
phase of infection in cynomolgus macaques monkeys
infected with group A Streptococcus [6]. However, a
mcra deletion mutant in Streptococcus pyogenes showed
only mild alteration in virulence properties, such as
blood survival, adherence and internalization to human
keratinocytes [1]. Dunman et al. (2001) found the mcra
gene was down-regulated by Agr, one of the most stu-
died virulence response regulators in Staphylococcus
aureus, along with other cell surface virulence factors
[7]. Growth-phase associated regulation of the mcra
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gene was abrogated in a rgg mutant strain of Streptococ-
cus pyogenes causing the mutant strain to synthesize the
protein during both the exponential and stationary
phases of growth, in contrast to the wild-type strain
which only synthesized the protein in the exponential
phase of growth. The transcriptional regulatory protein
Rgg coordinates amino acid catabolism and virulence
factor expression in Streptococcus pyogenes [8]. Also, the
mcra gene was up-regulated by the mgrA regulon in
Stapylococcus aureus. This regulon has been shown to
affect multiple Staphylococcus aureus genes involved in
virulence and antibiotic resistance, but also genes
involved in osmotic stress response (opuD (N315-
SA1987, encoding the glycine betaine transporter), proP
(N315-SA0531, encoding a proline/betaine transport
homolog) and gbsA (SA2406, encoding glycine betaine
aldehyde dehydrogenase)) [9].
The MCRA protein shows over 50% homology with
linoleate isomerases from Lactobacillus acidophilus
(Genbank: ABB43 157.1) and Lb. reuteri PYR8 linoleate
isomerase [10], a protein that catalyses the formation of
(9Z, 11E)-CLA from linoleic acid. CLA refers to several
positional (9,11; 10,12; 11,13; etc.) and geometric (cis or
trans) isomers of linoleic acid C18:2 cis-9 (c9), cis-12
(c12) octadecadienoic acid] with conjugated double
bonds, and the (9Z, 11E) and (10E, 12Z) isomers in par-
ticular, have been shown to exert beneficial effects on
human metabolism, including anti- carcinogenic, anti-
diabetogenic and anti-atherogenic activities and body
composition alteration effects. CLA is formed via bio-
transformation of linoleic acid, as a direct result of the
action of the ruminal microbiota, of which Butyrivibrio
fibrisolvens is the foremost [11-13]. The mechanism of
microbial production of CLA was characterised using
washed cells of the strain Lb. acidophilus AKU 1137
[14] and involves the production of hydroxy fatty acids
as precursor to formation of CLA. When isolated and
introduced to the washed cells, these hydroxy fatty acids
were rapidly transformed to their respective CLA iso-
mers. Thus, CLA formation by Lb. acidophilus was
found to consist of two distinct steps, step one: the
hydration of linoleic acid to 10-hydroxy-18:1 and step
two: the subsequent dehydration and isomerisation of
these hydroxy fatty acids to the c9,t11 CLA and t9,t11
CLA isomers.
We have previously reported the ability of a range of
Bifidobacterium spp. to produce the c9,t11 CLA isomer
from free linoleic acid [15-17] and have shown that
administration of CLA producing B. breve NCIMB
702258 to mice and pigs in combination with linoleic
acid alters host tissue fatty acid composition [18],
including elevated liver c9,t11 CLA, coupled with reduc-
tions in the proinflammatory cytokines tumour necrosis
factor-a (TNF-a) and interferon-g (IFN-g). The enzyme
responsible for CLA production in Bifidobacterium has
not been reported. The aims of this study were 1) to
investigate if the MCRA protein from B. breve NCIMB
702258 was active as a fatty acid hydratase, by introdu-
cing the gene encoding MCRA into Corynebacterium
glutamicum and Lactococcus lactis and analysis of the
enzymatic activity of the expressed protein in the het-
erologous hosts and 2) to investigate whether this led to
increased stress tolerance in the new hosts, and thus we
report a role for MCRA in stress protection in B. breve.
Methods
Cultures and media
B. breve NCIMB 702258 was cultured in MRS media
(pH 6.0, Oxoid Ltd, Hampshire, UK) supplemented with
0.05% (w/v) L-cysteine hydrochloride (Sigma Chemical,
98% pure) under anaerobic conditions using anaerobic
jars with ‘Anaerocult A’ gas packs (Merck, Darmstadt,
Germany) at 37°C. Lactococcus lactis NZ9800 (a L. lactis
NZ9700 derivative which does not produce nisin
because of a deletion in the nisA gene, and contains the
nisRK signal transduction genes integrated on the chro-
mosome) was cultured at 30°C in M17 (Difco labora-
tories, USA) broth and/or agar containing glucose (0.5%
w/v). L. lactis carrying the plasmid pNZ8048 was routi-
nely cultured in the presence of chloramphenicol (5 μg/
ml) as a selective marker. Corynebacterium glutamicum
ATCC 13032 was cultured aerobically in BHI media
(Merck, Darmstadt, Germany) at 37°C. C. glutamicum
ATCC 13032 carrying the shuttle vector pCLIK 5a MCS
Pddh (BASF, Ludwigshafen, Germany) was routinely
cultured in the presence of kanamycin (20 μg/ml) as a
selective marker. Escherichia coli JM109(DE3) carrying
the plasmid pOXO4 was routinely cultured aerobically
in BHI at 37°C in the presence of chloramphenicol
(25 μg/ml) as a selective marker.
DNA sequence analysis and primer design
The sequence encoding the 67 kDa MCRA (linoleate
isomerase) protein from Lb. reuteri PYR8 [19] was com-
pared to sequence databases (GenBank and unfinished
genomes databases), using the BLAST suite of programs
[20]. Proteins exhibiting significant similarity were
aligned using DNAStar software (DNAStar Inc. Madi-
son, WI, USA) and conserved motifs were identified.
Degenerate oligonucleotide primers and primers specific
for bifidobacteria (considering bifidobacteria codon
usage) were designed to these motifs (YWXTMF AFE
and DTVFTTEYS, Figure 1) and used in PCR reactions
to amplify a ~1 kb internal region of the sequence as
follows: Primer EV1a forward and EV2a reverse general,
degenerate): 5’- TA(C/T),TGG,III,ACI,ATG,TT(C/T),
GCI,TT(C/T),GA(A/G)-3’ and 5’- GA,GA(T/A),(T/C)
TC,IGT,IGT,(G/A)AA,IAC,IGT,(G/A)TC 3’, EV1b
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forward and EV2b reverse (specific for bifidobacteria
codon usage): 5’-TAC,TGG,III,ACC,ATG,TTC,GCI,
TTC,GAA-3’ and 5’- GA,GTA,TTC,(G/A)GT,(G/A)GT,
GAA,GAC,(G/A)GT,(G/A)TC 3’. PCR reactions were
performed in a Hybaid PCR Express Unit (Hybaid Ltd.
Middlesex, UK) in 50 μl with an annealing temperature
of 45°C. Each reaction contained 1 μl of each primer
(50 pmol/μl), 2 μl of template in 5 μl MgCl2 (50 mM),
5 μl dNTP Master Mix (12.5 mM), 50 μl 10x NH4 Reac-
tion Buffer and 0.5 μl Biotaq DNA Polymerase (5 U/μl)
(BIOLINE, London, UK). The resulting ~1 kb fragment
was cloned into pCR 2.1- TOPO and sequenced (MWG,
Germany).
Chromosome walking by inverse PCR
To obtain flanking chromosomal sequence, two primers
were designed to terminal regions of the known chro-
mosomal DNA sequence (Additional file 1). The geno-
mic DNA from B. breve NCIMB 702258 was digested
with a range of restriction enzymes followed by ligation
with DNA ligase as described by the supplier (New Eng-
land BioLabs Inc. Hertfordshire, UK). The circularized
fragments were subsequently used as templates in the
inverse PCR reactions with the terminal primers. The
reactions were performed in the same way as the stan-
dard PCR reactions but with an annealing temperature
of 50°C and the resulting fragments (analysed after
separation by agarose gel electrophoresis) were cloned
into the pCR2.1-TOPOvector and sequenced. The two
terminal primers used were Primer A (upstream): 3’-
CGTTCTCGACCTTGGTGTTGTATCGGAATT 5’ and
Primer B (downstream): 5’ -GTACCGACCGACAA
GATCGAGTCGCTTGCC-3’. From the approach
described above, it was confirmed by sequencing that
the 3’ end of the gene was obtained from re-circularized
XbaI digests; however the 5’ end was not yet acquired.
A second round of inverse PCR was performed with pri-
mers A (upstream) (3’- CGTTCTCGACCTTGGTG
TTGTATCGGAATT-5’) and pCS0 1 (downstream) (5’
GCATCGATGTCAGCCAGG-3’) targeted to re-circular-
ized KpnI digests of genomic DNA, which provided
another 370 bp of the upstream region of the gene. The
last round of inverse PCR to obtain the missing 170 bp
from the 5’ end of the gene was carried out with pri-
mers ER001 (5’-TCGATGGAGGGAATCGAA-3’) and
ER002 (5’-TATTGGCTCAACAAGGAAGAT-3’) tar-
geted to circularized HaeII digests.
DNA manipulations and plasmid construction
Genomic DNA was isolated from B. breve NCIMB
702258 by a modified method described by Hoffmann
et al. (1987) [21]. The 1878 mcra gene from B. breve
NCIMB 702258 (Genbank: HQ593838) was amplified
from genomic DNA with primers EMY01 and EMY02
(Table 1). PCR was performed with High Fidelity
Expand Polymerase as described by the supplier (Roche
Diagnostics, England) using 200 ng genomic DNA as a
template. PCR conditions were as follows: 10 cycles of
2 min, 15 s denaturation (94°C), 30 s annealing (55°C),
2 min elongation (72°C) followed by 20 cycles of 15 s
(94°C), 30 s (55°C), 2 min + 5 s/cycle (72°C) and finally,
one 7 min cycle at 72°C.
The mcra gene was amplified with primers EMY03
and EMY04 (Table 1) for cloning in pCLIK, resulting in
the construct pEMYC2 which was transformed into
C. glutamicum. Recombinant plasmids were double
digested with the same enzymes to verify the correct
clone and electroporated into L. lactis NZ9 800 and C.
glutamicum ATCC 13032. Electrocompetent L. lactis
were prepared and transformed according to the method
+ Majority
Y W K T M F A F EMajority
Y W K T M F A F E  S. aurues CLA ISOM.PRO
Y W A T M F A F E  Strep. pyogenes contig1 CLA.PRO
Y W A T M F A F E  Strep. pyogenes CLA isom protein.PRO
Y W A T M F A F E  Strep pyogenes manfredo.PRO
Y W C S M F A F E  Ent faecalis.PRO
Y W K T M F A F E  S. aureus 8082.PRO
Y W K T M F A F E  S aureus contig 76 prot..PRO
Y W K T M F A F E  S aureus contig 99 PRO.PRO
Y W S T M F A F E  S. mutans contig 80.PRO
Y W R T M F A F E  S. mutans contig 63.PRO
Y W S T M F A F E  L. reuteri CLA-isomerase.PRO
D T V F T T E Y S
--------- 
Motif #1 Motif #2 
D T V F T T E Y S  
D T V F T T E Y S  
D T V F T T E Y S  
D T V F T T E Y S  
D T V F T T E Y S  
D T V F T T E Y S  
D T V F T T E Y S  
D T V F T T E Y S  
D T I F T T E Y S  
D T V F T T E Y S  
Figure 1 Motifs used to design forward and reverse primers targeted to B. breve NCIMB 702258 mcra gene.
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described by de Ruyter et al. (1996) [22], while electro-
competent C. glutamicum cells were prepared as
described by Luchansky et al. (1988) [23]. For enzymatic
assays, the recombinant B. breve MCRA protein was
produced in E. coli as N-terminal 6x His-tag fusion. The
complete mcra gene was amplified using primers
BBI_fw2 and BBI_rv2 (Table 1). Ligation with pET28
vector (Novagen) resulted in a construct pBBI2 contain-
ing N-terminal fusion of 6x His tag and B. breve MCRA
protein. The authenticity of the clones was verified by
sequencing (MWG-BIOTECH, Germany).
Investigation of the stress tolerance of MCRA protein-
overproducing L. lactis and C. glutamicum
The MCRA protein was expressed in lactococci using the
NICE system [22], which allows maximal protein expres-
sion at sub-lethal concentrations of nisin, and is tightly
controlled, such that there is negligible expression in the
absence of nisin [24]. The MCRA protein was also
expressed in C. glutamicum using the shuttle vector
pCLIK 5a MCS Pddh. This vector replicates in both
E. coli and C. glutamicum and contains a C. glutamicum
promoter (ddh promoter) and a kanamycin resistance
gene which function in both E. coli and C. glutamicum.
L. lactis pNZ8048 and pEMYL1 cells were induced with
nisin (10 ng/ml) at OD600 nm ~ 0.5 and cultures were
left to grow for an additional 1.5 h prior to heat treat-
ment. C. glutamicum pCLIK and pEMYC2 were grown
to OD600 nm ~ 0.4 - 0.5, prior to stress. Thermotoler-
ance of L. lactis and C. glutamicum was monitored at
51°C in broth over 30-40 min. Aliquots were removed at
0, 10, 20, 30 and 40 min, plated on agar and incubated at
30°C (L. lactis) and 37°C (C. glutamicum) for 72 h. Salt
tolerance was determined following resuspension in
broth containing 3 M NaCl (L. lactis) and 4.8 M NaCl
(C. glutamicum) and culture viability was monitored over
60-90 min with aliquots taken at 15 min intervals.
Solvent tolerance was determined on addition of butanol
1-5% (v/v), and survival was monitored over 90 min with
aliquots taken at 15 min intervals.
Heterologous expression, protein extraction and SDS-
PAGE
The putative linoleic acid isomerase was expressed in
pOXO4 in E. coli using the T7 system (pOXO4 is a T7
RNA polymerase dependent expression plasmid). E. coli
pOXO4 (control) and E. coli pEMYE3 cultures were aera-
ted vigorously until the OD600nm reached approximately
0.6, at which point isopropyl-b-D-thiogalactopyranoside
(IPTG) was added to final concentration of 0.5 mM to
induce expression of the T7 RNA polymerase. Aliquots
were taken at intervals after IPTG induction at 1, 3, 6
and 12 h for whole cell protein extraction and sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE). Similarly, L. lactis pEMYL1 and pNZ8048 (vector
control) were cultured to OD600nm ~0.5 and induced
with nisin (10 ng/ml) and allowed to grow for another
12 h prior to protein extraction. C. glutamicum pEMYC2
and pCLIK (vector control) were cultured as described
previously for 24 h prior to protein extraction. To extract
proteins, cells (9 ml) were harvested and washed in
20 mM Tris HCl, pH 7.5 and resuspended in 0.5 ml
extraction solution (20 mM Tris-HCl, pH 7.5, 8 M Urea
and Chaps (0.5% w/v)) and bead-beaten for 2 × 30 sec
with 1 min rest on ice. The cell lysate was then centri-
fuged to remove beads and cell debris and the protein
extracts analysed by SDS-PAGE using a Mini Protean II
cell unit (Bio-Rad) by the method of Laemmli [25] with a
10% acrylamide resolving gel and 4% stacking gel. A low
molecular weight standard ranging from 14,400 to 97,400
Da (BioRad) was used as a molecular weight marker.
Production and purification of recombinant B. breve
MCRA protein from E. coli
For protein production, E. coli BL21 Star strain (Invitro-
gen, Darmstadt Germany) harboring pBBI2 plasmid was
used. Bacteria were cultivated in 2xYT medium (tryp-
tone (30 g/L), yeast extract (15 g/L), NaCl (5 g/L)) sup-
plied with kanamycin (25 μg/ml) at 37°C until OD600
reached 0.6. At that point, IPTG was added to final con-
centration of 0.1 mM, the cells were changed to 16°C
Table 1 Primers used in this work. Restriction sites are underlined
Primer Restriction site Resulting construct Sequence
EMY01 PstI pEMYL1 5 ‘- AACTGCAGTGGATTGTCAATTCATCCCC- 3 ‘
EMY02 HindIII 5’ - CCCCAAGCTTGCCCGATTATGCGAACGGCT- 3’
EMY03 NdeI pEMYC2 5 ‘- AACATATGTGGATTGTCAATTCATCCCC- 3 ‘
EMY04 AvrII 5’ - CCCCCCTAGGGCCCGATTATGCGAACGGCT- 3’
BBI_fw2 NdeI pBBI2 5 ‘ - AACATATGTACTACAGCAGCGGCAACTATGAG- 3 ‘
BBI_rv2 XhoI 5 ‘ - TCTCGAGTTAGATCACATGGTATTCGCGTAGCAGGGTAGC- 3 ‘
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and harvested by centrifugation (10 min at 9100 g) after
18 h induction time. Cells were resuspended in buffer A
(0.1 M Tris/HCl, pH 8.0, 0.15 M NaCl) in 1:3 v/v ratio,
frozen in liquid nitrogen and stored at -20°C.
For protein purification, cells were lysed by adding
lysozyme (0.1 mg/ml) and DNaseI (1 μg/ml) in buffer A
and 10 mM MgCl2 and centrifuged for 20 min at
70,000 g. The supernatant was loaded on HisTrap col-
umn (GE Healthcare, Sweden), the column was washed
with 10 column volumes of buffer A, and the protein
was eluted with 3 column volumes of buffer A and
0.5 M imidazol. After elution, the buffer was exchanged
to buffer B (0.1 M Tris/HCl, pH 7.5, 150 mM NaCl) by
ultrafiltration and protein concentration was estimated
spectrophotometrically using calculated absorption coef-
ficient ε280 = 116990.
Immunoblotting
10 μg of protein were subjected to SDS PAGE followed
by protein transfer to nitrocellulose membrane at 60 V,
4 mA/cm2 gel surface for 1 h. The membrane was
washed with buffer B and blocked for one hour in buffer
B containing 5% (w/v) milk powder. His-tagged proteins
were detected using anti-His tag antibody (Sigma) in
combination with a secondary antibody coupled with
alkaline phosphatase and nitrotetrazolium blue/5-
bromo-4-chloro-3-indolylphosphate staining.
Spectroscopic assays
Solution of purified B. breve MCRA protein had yellow
colour, therefore for initial characterization UV-Vis
spectrum of purified protein in the range 300-600 nm
was recorded with a single beam absorption spectro-
meter (Ultrospec 2100 pro, GE Healthcare). For the
reference, spectra of FAD and FMN in Buffer B were
recorded in the same way. For these measurements,
B. breve MCRA protein, FAD and FMN were brought
within the concentration range 10-40 pM. The absence
of covalent bond between cofactor and B. breve MCRA
protein was confirmed in the following way; 200 pl of
the protein (10 mg/ml in 50 mM Tris/HCl, pH 7.5) was
boiled for 10 min at 100°C and centrifuged at 12,000 g
for 10 min. The spectrum of the supernatant was then
recorded as described above.
Activity assay, lipid extraction and derivatization
To demonstrate the enzymatic activity of B. breve MCRA
protein, a panel of free fatty acids was tested in the
reactions with the purified protein. Typically, 10-50 pg
of substrate was mixed with 10 pg of purified protein in 1
mL of buffer B and incubated for 1 h at 25°C. Fatty acids
were extracted from the reaction mixture with 1 ml
chloroform:methanol (1:1) according to Bligh and
Dyer [26]. Free fatty acids were dissolved in methanol
and converted to corresponding methyl esters with
(trimethylsilyl)-diazomethane. For GC- MS analysis, fatty
acid methyl esters were dissolved in acetonitrile and
hydroxy groups were modified by N,O-bis-(trimethylsi-
lyl)-trifluoroacetamide (BSTFA), resulting in fatty acid
trimethylsilylethers. GC-MS analysis was performed as
previously described [27].
Phylogenetic analysis
Homologs to the previously identified linoleate isomer-
ase from Lb. acidophilus (Genbank: ABB43 157.1) and
oleate hydratase, Elizabethkingia meningoseptica (Gen-
bank: GQ144652) were selected from BLAST analysis.
These homologs, along with MCRA from B. breve
NCIMB 702258 discussed in this manuscript were
aligned using T-Coffee [28] and protein trees were built
using the PHYLIP package [29]. The cladogram was
then visualised using DENDROSCOPE [30].
Results
Previous studies by Rosson et al. [10] reported on the
isolation and purification of a putative linoleic acid iso-
merase from Lb. reuteri. In these studies, protein
sequencing had identified a 67 kDa protein with homol-
ogy to MCRA. Based on this finding, we designed pri-
mers to conserved regions shared by a range of MCRA
proteins in the database (Figure 1) and found that we
could PCR the gene from a range of different Bifidobac-
terium strains and Propionibacterium freudenreichii
shermanii (Additional file 2). Given that B. breve
NCIMB 702258 is known to be capable of producing c9,
t11 CLA from linoleic acid [16], we decided to study
this strain in terms of CLA production. Using primers
EV1a forward and EV2a reverse, we amplified a 1 kb
internal fragment of the putative isomerase gene from
B. breve. Sequencing of this revealed up to 70% homol-
ogy to MCRA proteins from various genera. Following
this, we primer walked in both 5’and 3’ directions,
which resulted in the full sequence of B. breve putative
isomerase (Additional file 1).
Sequence analysis
The complete 1878 bp nucleotide sequence from B. breve
NCIMB 702258 encodes a protein of 626 amino acids
with homology to other “67 kilodalton MCRA” proteins.
The calculated molecular weight of the protein is
70535.38 Da. Comparison with sequences in the database
revealed that the cloned MCRA protein showed 71%
homology with putative 67 kDa MCRA from Streptococ-
cus mutans UA159 (Genbank: NP_720953) and 51%
homology with Lb. acidophilus linoleate isomerase (Gen-
bank: ABB43 157.1). A non-canonical flavin binding
motif (GxGxxA(x)21E) is present at the N-terminus
of B. breve MCRA protein, similar to Streptococcus and
Rosberg-Cody et al. BMC Biochemistry 2011, 12:9
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Lactobacillus MCRA proteins [31]. The protein is
cytoplasmic, but may have one trans-membrane helix as
predicted by PSORTb (http://www.psort.org/). Upstream
of the ORF is a putative dehydrogenase or reductase pro-
tein with ~50% homology with B. longum NCC2705 2,5-
diketo-D-gluconic acid reductase (Genbank: AAN24097).
Downstream of the TGA stop codon is a region of dyad
symmetry, capable of forming a stable stem-and-loop
structure. The potential hairpin consists of 13-bp stem
separated by a 3-bp mis-priming and a 5- bp loop (ΔG,
-15.01 kcal).
Over-expression of B. breve MCRA protein in E. coli
Since no over-expression of the putative linoleic acid
isomerase could be confirmed following SDS-PAGE of
the recombinant lactococci and corynebacteria, possibly
due to masking of the protein by other proteins of simi-
lar molecular weight (Additional file 3), the putative lai
(linoleic acid isomerase) gene was expressed in pOXO4
in E. coli using the T7 system (pOXO4 is a T7 RNA
polymerase dependent expression plasmid). Following
growth and induction at OD600nm 0.6 with 0.5 mM
IPTG, aliquots of E. coli pOXO4 (control) and E. coli
pEMYE3 were taken at 1, 3, 6 and 12 h after induction
for whole cell protein extraction and SDS-PAGE. A pro-
tein band of approximately 66 kDa was visualized, corre-
sponding to the expected molecular weight of the
putative isomerase protein, which was absent in the
IPTG induced control culture E. coli pOXO4 (Addi-
tional file 3). Following incubation for 48-72 h with free
linoleic acid (0.5 mg/ml), the substrate for bacterial
conversion to c9,t11 CLA, no isomerase activity could
be confirmed among the heterologous clones carrying
the lai gene in the bacterial supernatant by GC (Addi-
tional file 4), or by measuring OD234 nm [17].
Production of B. breve MCRA in E. coli. and enzymatic
assays
B. breve MCRA protein was overproduced in E. coli and
purified on Ni2+-NTA column (Figure 2A, lane 2). The
major band with apparent molecular weight of 66 kDa
was visualized on SDS PAGE after the elution. Immuno-
blotting with anti-His tag antibodies confirmed that this
band contained 6x His tag (Figure 2A, lane 3). Purified
B. breve MCRA protein has flavin-like UV-Vis absorp-
tion spectrum with maxima around 450 and 370 nm
(Figure 2B) and the flavin cofactor is released in the
solution upon protein denaturation by heat. The spectral
properties of B. breve MCRA are consistent with a
recombinant MCRA protein from S. pyogenes, which
was found to contain a non-covalently bound FAD and
exhibited double bond hydratase activity producing
10- and 13-hydroxy fatty acids [1]. These data prompted
us to examine the enzymatic activity of B. breve MCRA
using common C16 and C18 fatty acids as substrates.
To this end, purified protein was incubated with free
fatty acids and the reaction products were analyzed by
GC-MS. Indeed, we observed conversion of palmitoleic,
oleic and linoleic acids to the corresponding 10-hydroxy
fatty acids (Figure 3 and Table 2), but myristoleic acid
or shorter monounsaturated fatty acids were not sub-
strates. The presence of trans-double bonds as well as
A B 
Figure 2 Spectral analysis of purified B. breve MCRA protein. SDS PAGE analysis of B. breve MCRA protein purified on Ni-NTA column. Lane
1, molecular weight marker, lane 2, B. breve MCRA protein of apparent MW of 66 kDa, lane 3, immunoblot with anti-His tag antibody shows the
absence of significant proteolytic degradation in purified B. breve MCRA. B UV-Vis spectrum of B. breve MCRA protein (black) and the supernatant
after heat precipitation (red), showing flavin-like absorbance. For the reference spectra of 10 μM FAD (blue) and FMN (magenta) are shown.
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the double bonds beyond the position C12 abolished
hydratase activity. No conversion of esterified fatty acids
such as methyl linoleate or CLA isomers was observed.
Phylogenetic analysis
Figure 4 displays a phylogenetic analysis of MCRA
from B. breve NCIMB 702258 along with both
linoleate isomerase and oleate hydratase homologs.
The tree clearly illustrates distinct groupings of the
two sets of homologs. Interestingly, our MCRA protein
branches in between both groupings but appears to be
evolutionary closer to the hydratase group. This result
further supports our finding of the MCRA as fatty acid
hydratase.
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Figure 3 Mass spectra of reaction products from the incubations of B. breve MCRA protein with free fatty acids. A) Fragmentation
pattern of 10-HOE. B) Mass spectrum of 10-HOE obtained after the incubation with linoleic acid. C) Mass spectrum of 10-HO obtained after the
incubation with oleic acid. D) Mass spectrum of 10-HH obtained after the incubation with palmitoleic acid.
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Stress tolerance of MCRA-overproducing Lactococcus and
Corynebacterium
To determine if heterologous Lactococcus and Coryne-
bacterium containing the mcra gene exhibited improved
stress tolerance, the heterologous cultures along with
vector controls of Lactococcus (pNZ8048) and Coryne-
bacterium (pCLIK) were assayed for hydratase activity
by measuring 9-hydroxy fatty acids without and with
linoleic acid supplementation of the medium. Indeed,
those cultures that expressed MCRA/hydratase accumu-
lated increasing amounts of 10-HOA and 10-HOE in
the culture medium (Additional file 5). Next, the hetero-
logous cultures were exposed to heat (51°C × 30-40 min),
salt (3 M NaCl × 90 min - Lactococcus and 4.8 M NaCl ×
90 min - Corynebacterium) and solvent (3% (v/v) butanol
× 45-60 min) stresses. L. lactis pNZ8048 reduced in via-
bility by 4 Log CFU/ml following heat stress at 51°C for
40 min, whereas L. lactis pEMYL1 only reduced in viabi-
lity by 2 Log CFU/ml (Figure 5A, B). The difference in
survivability between C. glutamicum pCLIK and
pEMYC2 was ~0.5 Log CFU/ml when heat stressed at
51°C for 30 min, a decline in survivability by <0.5 Log
CFU/ml for L. lactis pEMYL1 and <1 Log CFU/ml for
C. glutamicum pCLIK (vector control).
Similarly, when induced L. lactis pNZ8048 was
exposed to solvent stress (3% (v/v) butanol), a decrease
in viability of >3.3 Log CFU/ml was observed, whereas
induced L. lactis pEMYL1 only decreased ~1.5 Log
CFU/ml following 60 min in 3% (v/v) butanol, i.e. a dif-
ference of nearly 2 Log CFU/ml between the cultures
under identical conditions. C. glutamicum pEMYC2
exposed to 3% (v/v) butanol stress for 45 min survived
~ 0.75 Log CFU/ml better than the vector control
(pCLIK) (Figure 5C-E).
Upon confirming that the clones containing the
MCRA protein were less sensitive to heat and solvent
stresses, we examined the hypothesis that the protein
also protected the cultures from salt stress. Following
growth and induction by nisin (10 ng/ml at OD600 nm
~0.5) and additional growth for 1.5 h, L. lactis pNZ8048
(control) and pEMYL1 cultures were exposed to 3 M
NaCl for 90 min. However, no difference in salt toler-
ance was observed at concentrations of 3 M NaCl. A
similar observation was made for C. glutamicum pCLIK
and pEMYC2 which were grown in 4.8 M NaCl for 90
min. Both C. glutamicum control (pCLIK) and pEMYC2
cultures survived in 4.8 M NaCl for 90 min with no
apparent decline in viable numbers (Figure 5F, G).
Discussion
Several recent reports have linked MCRA and oleic acid
hydratase activity [1-3], which was first observed more
than forty years ago in Pseudomonas sp. [32]. However,
the significance of this hydratase activity for the bacter-
ial host is not yet clearly established. Our study identi-
fied MCRA from B. breve as a FAD-containing
hydratase with an additional role in stress protection
(Figures 2 and 3, Table 2). Interestingly, a recent study
by O’Flaherty and Klaenhammer (2010) indicated a role
for MCRA in stress tolerance, cell wall division and
adherence to Caco-2 cells [33]. Furthermore, all three
characterized enzymes from this family are highly speci-
fic for free fatty acids as the previously characterized
linoleic acid isomerase from P. acnes [1,2,34]. Thus,
both enzyme activities seem to form a new class of
FAD-dependent fatty acid modifying enzymes. This find-
ing may be even further supported by phylogenetic
groupings (Figure 4). Given the wide distribution of the
mcra gene between human pathogenic and commensal
bacteria, it could be speculated that it is not directly
linked to virulence but to a general stress protection,
which could also be useful for a pathogen i.e. increased
heat at the site of infection. Our study confirmed the
increased viability of heterologous Lactococcus and Cory-
nebacterium transformed with the mcra gene during
heat and solvent stresses as a difference in viability of 2
Log CFU/ml following heat stress at 51°C for 40 min
and 3% (v/v) butanol stress for 60 min was observed
between L. lactis pEMYL1 and pNZ8048 (Figure 4A-E).
Likewise, the introduced MCRA improved the surviva-
bility of C. glutamicum by ~0.5 Log CFU/ml difference
between C. glutamicum pCLIK and pEMYL1 following
Table 2 Reaction products of recombinant purified
B. breve MCRA protein
Substrate Product RT,
min
MS fragments, m/z
14: 1A9Z No
products
- -
16:1A9Z (PA) 10-HH 8.13 357(M-1)+, 273, 187, 169
18:1A9Z (OA) 10-HO 9.56 385(M-1)+, 273, 215, 169
18:1A11Z No
products
- -
18: 1A9E No
products
- -
18:2A9Z,12Z (LA) 10-HOE 9.84 383(M-1)+, 273, 213, 173,
169
18:2A9Z,A12Z
No products - -
methyl ester
CLA mixture No
products
- -
18:2A9E,12E No
products
- -
18: 3A9Z,12Z,15Z (LeA) No
products
- -
20:4A5Z,8Z,11Z,14Z
(AA)
No
products
- -
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heat stress at 51°C for 30 min, and ~0.75 Log CFU/ml
following 3% (v/v) butanol stress for 45 min (Figure 5).
The same host, L. lactis NZ9800 has previously been
used for comparative studies of stress performance fol-
lowing transformation with the well known heat shock
protein GroESL in plasmid pNZ8048. Desmond et al.
(2004) [35] compared the viability of induced (nisin
10 ng/ml) and heat treated cells at 54°C for 30 min of
the same host L. lactis NZ9800 transformed with either
pNZ8048 or pNZ8048-GroESL. At that temperature,
both L. lactis pNZ8048 and un-induced L. lactis
pNZ8048-GroESL (pGRO1) reduced in viability by 4.0
log CFU/ml, whereas the induced L. lactis (pGRO1)
declined by 3.3 Log CFU/ml during the heat stress.
Furthermore, induced GroESL-overproducing L. lactis
(pGRO1) was able to grow and increase by 0.5 Log
CFU/ml during 5 h exposure to 0.5% (v/v) butanol,
compared with L. lactis (pNZ8048) and un-induced
L. lactis (pGRO1) which declined in viability after 1 h
(0.2 Log CFU/ml), a trend that continued over the 6 h
period of solvent challenge.
It has been reported that the response of cells to sub-
lethal heat and ethanol exposure induce essentially iden-
tical stress responses because of the alteration in the
membrane fluidity by these stresses [36]. Heat and etha-
nol stresses cause similar changes to plasma membrane
protein composition, reducing the levels of plasma
membrane H+- ATPase protein and inducing the plasma
membrane-associated Hsp30. Both stresses also stimu-
late the activity of the fraction of H+-ATPase remaining
in the plasma membrane. The resulting enhancement to
catalysed proton efflux from the cell represents a con-
siderable energy demand, yet may help to counteract
the adverse effects for homeostasis of the increased
membrane permeability that results from stress.
Conclusions
This study has shown that the MCRA protein in bifido-
bacteria is a FAD containing hydratase enzyme, which
may be catalysing the first step in CLA production in
this species, and has an additional function in bacterial
stress protection.
Figure 4 Phylogenetic tree of linoleate isomerase and oleate hydratase homologs. (accession numbers for each homolog are included).
The placement of MCRA protein from B. breve NCIMB 702258 is highlighted in red. All branches are supported at >75% bootstrap values.
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Figure 5 Effect of B. breve MCRA expression on survivability of L. lactis and C. glutamicum strains under stress conditions.
A) Survivability of L. lactis pNZ8048 (’black square’) versus pEMYL1 (’upside down black triangle’) following heat treatment at 51°C for 40 min.
**Denotes value significantly different (p = 0.01) than control (pNZ8048). B) Survivability of C. glutamicum pCLIK (’black square’) versus pEMYC2
(’black triangle’) following heat treatment at 51°C for 30 min * Denotes value significantly different (p = 0.05) than control (C. glutamicum pCLIK).
C) Survivability of C. glutamicum pCLIK (’upside down black triangle’) versus pEMYC2 (’black square’) following growth in 1-5% (v/v) butanol for
1 h. D) Survivability of L. lactis pNZ8048 (’black triangle’) versus pEMYL1 (’black square’) following nisin induction for 1.5 h prior to growth in 3%
(v/v) butanol for 1 h. The experiments were done at least in triplicate. * Denotes value significantly different (p = 0.05) than control (pNZ8048). E)
Survivability of C. glutamicum pCLIK (’upside down black triangle’)versus pEMYC2 (’black square’) following growth in 3% (v/v) butanol for
45 min. F) Survivability of C. glutamicum pCLIK (’black triangle’)versus pEMYC2 (’black square’) following growth in 4.8 M NaCl for 90 min.
G) Survivability of L. lactis pNZ8048 (’black triangle’) versus pEMYL1 (’black square’) following nisin induction for 1.5 h prior to growth in 3 M NaCl
for 90 min. The experiments were done in triplicate.
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Additional material
Additional file 1: Map of putative isomerase gene. Map of putative
isomerase gene and chromosome walking strategy (inverse PCR) used to
obtain the full sequence.
Additional file 2: Mcra gene sequence data from Bifidobacterium
strains and Propionibacterium freudenreichii shermanii. 1 kb PCR
fragments following PCR of genomic DNA from a range of bifidobacterial
strains and Propionibacterium freudenreichii shermanii 9093 using
oligonucleotide primers EV1a forward and EV2a reverse. Lanes 1-12 in
the following order; B. adolescentis; B. breve 2257; B. breve 702258; B. breve
8815; B. dentium 2243; B. infantis 2205; B. lactis Bb 12; B. longum 2259; B.
longum BB 536; Bifidobacterium sp. 35612; Bifidobacterium sp. 35687;
Propionibacterium freudenreichii shermanii 9093.
Additional file 3: Putative linoleic acid isomerase protein. Panel A. E.
coli JM109(DE3) pOXO4 (lanes 1-4) and pEMYE3 (lanes 5- 8) induced with
0.5 mM IPTG. Samples taken after 1, 3, 6 and 12 h growth for protein
extraction and SDS-PAGE. Panel B. C. glutamicum pCLIK (lane 1) and
pMYC2 (lane 2) following 24 h growth prior to protein extraction. Panel
C. L. lactis pNZ4848 (lanes 1-2) and pEMYL1 (lanes 3-4) following
induction with nisin 0 and 10 ng/ml, respectively, and further growth for
12 h prior to protein extraction.
Additional file 4: CLA forming activity in bacterial strains expressing
MCRA from B. breve. GC chromatogram of supernatant from B. breve
NCIMB 702258 (positive control), L. lactis pEMYL1 (carrying laiA gene),
and L. lactis pNZ8048 (vector control) following growth in linoleic acid
(0.1 mg/ml) (L. lactis) and (0.5 mg/ml (B. breve) for 48-72 h. Similar results
were obtained for recombinant C. glutamicum and E. coli.
Additional file 5: Hydratase activity in bacterial strains expressing
MCRA from B. breve. Amounts of 10-HOA (black bars) and 10-HOE (gray
bars) in supernatant from L. lactis pEMYL1 (carrying MCRA gene), and L.
lactis pNZ8048 (VC, vector control) following growth in linoleic acid (0.1
mg/ml) (L. lactis) for 2-30 h. Data represent the mean values of 3
measurements. Similar results were obtained for recombinant C.
glutamicum.
Abbreviations
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